Washington, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

Commission File No.  0-10783

(Check one): [  ] Form 10-K [  ] Form 20-F [X] Form 10-Q [  ] Form N-SAR 
             [  ] Form N-CSR

                  For Period Ended: May 31, 2005 
                  [ ] Transition Report on Form 10-K 
                  [ ] Transition Report on Form 20-F 
                  [ ] Transition Report on Form 11-K 
                  [ ] Transition Report on Form 10-Q 
                  [ ] Transition Report on Form N-SAR
                  [ ] Transition Report on Form N-CSR 
                  For the Transition Period Ended:

Nothing  in this  form  shall be  construed  to imply  that the  Commission  has
verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the Item(s) to which the notification relates: N/A


Full Name of Registrant:  BSD Medical Corporation
Former Name if Applicable:  N/A
Address of Principal Executive Office (Street and Number):  2188 West 2200 South
City, State and Zip Code:  Salt Lake City, Utah  84119

PART II-- RULES 12b-25(b) AND (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

              (a)  The reason described in reasonable detail in Part III of this
                   form could not be eliminated without unreasonable effort or
              (b)  The subject annual report, semi-annual report, transition
                   report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form
                   N-CSR, or portion thereof, will be filed on or before the
    [X]            calendar day following the prescribed due date; or the
                   subject quarterly report or transition report on Form l0-Q,
                   or portion thereof, will be filed on or before the fifth
                   calendar day following the prescribed due date; and
              (c)  The accountant's statement or other exhibit required by Rule
                   12b-25(c) has been attached if applicable.


State below in reasonable detail why forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR,
or the  transition  report or  portion  thereof,  could not be filed  within the
prescribed time period.

         BSD Medical Corporation (the "Company") hereby requests an extension of
time to file its  Quarterly  Report on Form 10-QSB for the period  ended May 31,
2005.  The Company  was unable to file its Form 10-QSB by July 15, 2005  without
unreasonable effort or expense because the Company needs more time to adequately
compile and analyze  supporting  documentation and provide such documentation to
its independent registered public accounting firm.  Consequently,  the Company's
independent  registered public accounting firm was unable to complete its review
of the Company's  financial  statements within the necessary period of time. The
Company  currently  anticipates  that the Form  10-QSB will be filed by no later
than the fifth calendar day following the date on which the Form 10-QSB was due.


(1)   Name and telephone number of person to contact in regard to this

              Dennis Bradley                 (801)                 972-5555
                  (Name)                  (Area Code)         (Telephone Number)

(2)   Have all other periodic reports required under Section 13 or 15(d) of the
      Securities Exchange Act of 1934 or Section 30 of the Investment Company
      Act of 1940 during the preceding 12 months (or for such shorter) period
      that the registrant was required to file such report(s) been filed? If
      answer is no, identify report(s). Yes [X] No [ ]

(3)   Is it anticipated that any significant change in results of operations
      from the corresponding period for the last fiscal year will be reflected
      by the earnings statements to be included in the subject report or portion
      thereof? Yes [ ] No [X]

If so, attach an explanation of the  anticipated  change,  both  narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.


                             BSD Medical Corporation
                  (Name of Registrant as Specified in Charter)

has  caused  this  notification  to be signed on its  behalf by the  undersigned
hereunto duly authorized.

Date: July 15, 2005                  By     /s/ Dennis Bradley    
                                          Name: Dennis Bradley
                                          Title: Principal Financial Officer

Instruction:  This form may be signed by an executive  officer of the registrant
or by any other duly authorized representative. The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.



BSD Medical Corporation
2188 South 2200 West
Salt Lake City, Utah  84119

Ladies and Gentlemen:

Pursuant to Rule 12b-25 of the General Rules and Regulations under the
Securities and Exchange Act of 1934, we inform you that we have been furnished a
copy of the Form 12b-25 to be filed by BSD Medical Corporation (the "Company")
on or about July 15, 2005, which contains notification of the Company's
inability to file its Quarterly Report on Form 10-QSB by July 15, 2005. We have
read the contents of Part III therein and we agree with the stated reasons as to
why we were unable to complete our review of the Company's financial statements
for the quarter ended May 31, 2005, to be included in the Quarterly Report on
Form 10-QSB, by July 15, 2005.

Very truly yours,